Wang J - Search Results

1

ATRA is effective to an acute promyelocytic leukemia patient without RARA gene rearrangement.

Song X, Gong S, Chen J, Gao L, Yang J, Wang J. Song X, et al. Among authors: wang j. Leuk Res. 2010 Aug;34(8):e190-3. doi: 10.1016/j.leukres.2010.02.003. Epub 2010 Mar 1. Leuk Res. 2010. PMID: 20189646 No abstract available.

2

[Combination of mycophenolate mofetil with cyclosporine A and methotrexate for the prophylaxes of acute graft versus host disease in allogeneic peripheral stem cell transplantation].

Wang J, Song X, Zhang W, Tong S, Hou J, Chen L, Lou J, Li H, Ding X, Min B. Wang J, et al. Zhonghua Yi Xue Za Zhi. 2002 Apr 25;82(8):507-10. Zhonghua Yi Xue Za Zhi. 2002. PMID: 12133492 Chinese.

3

Clinical and molecular cytogenetic characteristics of dic(9;20) in adult acute lymphoblastic leukemia: a case report of three patients.

Song X, Gong S, Yang J, Wang J. Song X, et al. Among authors: wang j. Ann Hematol. 2007 May;86(5):347-51. doi: 10.1007/s00277-007-0255-0. Epub 2007 Jan 24. Ann Hematol. 2007. PMID: 17245591

4

Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis.

Chen J, Du C, Kang J, Wang J. Chen J, et al. Among authors: wang j. Chem Biol Interact. 2008 Jan 10;171(1):26-36. doi: 10.1016/j.cbi.2007.09.004. Epub 2007 Sep 15. Chem Biol Interact. 2008. PMID: 17961528

5

Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line.

Lü S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P, Wang J. Lü S, et al. Among authors: wang j. J Pharmacol Exp Ther. 2008 Aug;326(2):423-31. doi: 10.1124/jpet.108.138131. Epub 2008 May 23. J Pharmacol Exp Ther. 2008. PMID: 18502982

6

Overexpression of the PSMB5 gene contributes to bortezomib resistance in T-lymphoblastic lymphoma/leukemia cells derived from Jurkat line.

Lü S, Chen Z, Yang J, Chen L, Gong S, Zhou H, Guo L, Wang J. Lü S, et al. Among authors: wang j. Exp Hematol. 2008 Oct;36(10):1278-84. doi: 10.1016/j.exphem.2008.04.013. Epub 2008 Jun 17. Exp Hematol. 2008. PMID: 18562081 Free article.

7

Bortezomib in combination with epirubicin, dexamethasone and thalidomide is a highly effective regimen in the treatment of multiple myeloma: a single-center experience.

Lü S, Wang J, Xu X, Ni X, Huang C, Qiu H, Hu X, Yang J. Lü S, et al. Among authors: wang j. Int J Hematol. 2009 Jan;89(1):34-38. doi: 10.1007/s12185-008-0218-9. Epub 2008 Dec 13. Int J Hematol. 2009. PMID: 19082817 Clinical Trial.

8

Appearance of anaphylactic shock after long-term intravenous itraconazole treatment.

Chen J, Song X, Yang P, Wang J. Chen J, et al. Among authors: wang j. Ann Pharmacother. 2009 Mar;43(3):537-41. doi: 10.1345/aph.1L343. Epub 2009 Mar 3. Ann Pharmacother. 2009. PMID: 19261964

9

Different mutants of PSMB5 confer varying bortezomib resistance in T lymphoblastic lymphoma/leukemia cells derived from the Jurkat cell line.

Lü S, Yang J, Chen Z, Gong S, Zhou H, Xu X, Wang J. Lü S, et al. Among authors: wang j. Exp Hematol. 2009 Jul;37(7):831-7. doi: 10.1016/j.exphem.2009.04.001. Epub 2009 May 6. Exp Hematol. 2009. PMID: 19426847 Free article.

10

A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China.

Wang J, Lü S, Yang J, Song X, Chen L, Huang C, Hou J, Zhang W. Wang J, et al. J Hematol Oncol. 2009 Jul 30;2:32. doi: 10.1186/1756-8722-2-32. J Hematol Oncol. 2009. PMID: 19642997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219,956 results

Search Page

Filters